Get started
Author

Huttakan Navadurong

Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients
2024 · Yu Jun Wong, Vincent L. Chen, et al. · Hepatology · 45
Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
2023 · Huttakan Navadurong, Kessarin Thanapirom, et al. · World Journal of Gastroenterology · 31
Epidemiology and trends of alcohol use disorder and alcohol-associated liver disease
2023 · Elizabeth Lee, Huttakan Navadurong, et al. · Clinical Liver Disease · 23
PDF
Performance comparison between two computer-aided detection colonoscopy models by trainees using different false positive thresholds: a cross-sectional study in Thailand
2024 · Kasenee Tiankanon, Julalak Karuehardsuwan, et al. · Clinical Endoscopy · 10
PDF
Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver disease
2025 · Supatsri Sethasine, Padoemwut Teerawongsakul, et al. · World Journal of Gastroenterology · 9
Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy
2023 · Huttakan Navadurong, Thaninee Prasoppokakorn, et al. · World Journal of Gastrointestinal Oncology · 6
Urinary neutrophil gelatinase‐associated lipocalin: A novel biomarker for predicting chronic kidney disease in patients with nonalcoholic fatty liver disease
2022 · Huttakan Navadurong, Thaninee Prasoppokakorn, et al. · Portal hypertension & cirrhosis · 2
PDF
Toward personalized hepatocellular carcinoma surveillance: A risk-stratified approach
2026 · Huttakan Navadurong, Sombat Treeprasertsuk, et al. · World Journal of Gastrointestinal Oncology
PDF
Sequential 100-Hz spleen stiffness and ANTICIPATE-NASH enhance esophageal varices detection in Thai advanced chronic liver disease
2026 · Kwanchat Krairaweengarmwijitr, Witchakorn Ruamtawee, et al. · Scientific Reports
PDF
Time-dependent predictive accuracy of noninvasive liver scores for chronic kidney disease onset in metabolic dysfunction-associated steatotic liver disease
2026 · Huttakan Navadurong, Padoemwut Teerawongsakul, et al. · World Journal of Hepatology
PDF
IDDF2024-ABS-0119 Serial versus current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients: an intercontinental, multinational study
2024 · Yu Jun Wong, Vincent Chen, et al. · Gut
Sa1594 COMPARING SERIAL AND CURRENT LIVER STIFFNESS MEASUREMENTS TO PREDICT DECOMPENSATION IN COMPENSATED ADVANCED CHRONIC LIVER DISEASE PATIENTS
2024 · Yu Jun Wong, Vincent L. Chen, et al. · Gastroenterology
Tu1504 CAN ALBUMIN-BILIRUBIN (ALBI) SCORE CHANGE OVER TIME PREDICT 90-DAY MORTALITY IN HOSPITALIZED CIRRHOTIC PATIENTS? A MULTICENTER STUDY.
2023 · Huttakan Navadurong, Tongluk Teerasarntipan, et al. · Gastroenterology
PDF
Tu1539 MODIFIED ALBI PREDICTED SURVIVAL OF UNRESECTABLE HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH IMMUNOTHERAPY
2023 · Huttakan Navadurong, Roongruedee Chaiteerakij, et al. · Gastroenterology
PDF
Su1560 VALIDATION OF THE ALBUMIN-BILIRUBIN (ALBI) SCORE FOR IDENTIFY DECOMPENSATION RISK IN PATIENTS WITH COMPENSATED CIRRHOSIS
2023 · Huttakan Navadurong, Kessarin Thanapirom, et al. · Gastroenterology
PDF
IDDF2022-ABS-0166 Urinary neutrophil gelatinase-associated lipocalin (NGAL); a novel biomarker for predicting chronic kidney disease (CKD) in patients with non-alcoholic fatty liver disease (NAFLD)
2022 · Huttakan Navadurong, Sombat Treeprasertsuk, et al. · Gut
IDDF2022-ABS-0167 Performance of abbreviated magnetic resonance imaging versus ultrasonography as an imaging tool for hepatocellular carcinoma surveillance
2022 · Huttakan Navadurong, Khamik Laohasurayotin, et al. · Gut
Sa1416: PERFORMANCE OF ABBREVIATED MAGNETIC RESONANCE IMAGING VERSUS ULTRASONOGRAPHY AS AN IMAGING TOOL FOR HEPATOCELLULAR CARCINOMA SURVEILLANCE.
2022 · Huttakan Navadurong, Khamik Laohasurayotin, et al. · Gastroenterology
Sa1644 – Predictive Factors Associated with Liver Fibrosis Progression in Biopsy Proven Non-Alcoholic Fatty Liver (NAFL)
2019 · Panyavee Pitisuttithum, Huttakan Navadurong, et al. · Gastroenterology
PDF
Works count: 19
Citation count: 126
H-index: 6
I10-index: 4
Year
Topic
Type